剰余金の配当（中間配当）、Proceeds From Purchase Of Investments In Subsidiaries Resulting In Change In Scope Of Consolidation InvCF、その他他2件
- 【期間】
| 年度 | 剰余金の配当（中間配当） | Proceeds From Purchase Of Investments In Subsidiaries Resulting In Change In Scope Of Consolidation InvCF | その他 | 減損損失 - 医薬・バイオケミカル | 減価償却累計額 |
|---|
| 2008/12 | - | | 18.8億 | | - | | - | | -3953億 | |
| 2009/12 | - | | - | | - | | - | | -4037億 | 赤拡 |
| 2010/12 | - | | - | | - | | - | | -3756億 | 赤縮 |
| 2011/12 | -130億 | | - | | - | | - | | -3620億 | 赤縮 |
| 2012/12 | -130億 | 赤縮 | - | | - | | 13.4億 | | -3599億 | 赤縮 |
| 2013/12 | - | | - | | - | | 2.07億 | -84.6% | -3353億 | 赤縮 |
| 2014/12 | - | | - | | - | | 13.4億 | +548.3% | -3364億 | 赤拡 |
| 2015/12 | - | | - | | - | | 57.6億 | +329.4% | -3359億 | 赤縮 |
| 2016/12 | - | | - | | - | | 3.35億 | -94.2% | -3389億 | 赤拡 |
| 2018/12 | - | | - | | -851億 | | - | | - | |
| 2019/12 | - | | - | | -919億 | 赤拡 | - | | - | |
| 2020/12 | - | | - | | -280億 | 赤縮 | - | | - | |
| 2021/12 | - | | - | | -402億 | 赤拡 | - | | - | |
| 2022/12 | - | | - | | -380億 | 赤縮 | - | | - | |
| 2023/12 | - | | - | | -297億 | 赤縮 | - | | - | |
